Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation.

Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation. Circ Heart Fail. 2020 02; 13(2):e006696.

View in: PubMed

subject areas

Aminobutyrates
Angiotensin II Type 1 Receptor Blockers
Biphenyl Compounds
Drug Combinations
Heart Failure
Heart Transplantation
Hemodynamics
Humans
Hypertension, Pulmonary
Neprilysin
Protease Inhibitors
Recovery of Function
Tetrazoles
Time Factors
Treatment Outcome
Valsartan
Waiting Lists

authors with profiles

Michael R. Zile